Although TMEM16A overexpression is observed in around 30% of HNSCC and is associated with cisplatin resistance, apoptosis, poor morbidity [13], and can activate EGFR/ERK pathway [14, 15], the connection between TMEM16A and p90RSK has not been previously explored. The gene discussed is ANO1; the disease is head and neck squamous cell carcinoma.